Last updated
Amgen: Cybersecurity Incident
Amgen experienced a cybersecurity incident with sensitive data stolen
Source: ETtech (Economic Times)
- What happened
- Amgen experienced a cybersecurity incident with sensitive data stolen
- Who
- Amgen · Biotech & Pharma · USA
- When
- 2026-07-31
- Source
- ETtech (Economic Times)
- So what
- A breach is a governance event before it is a technical one.
The leadership read
A breach is a governance event before it is a technical one. For Amgen in Biotech & Pharma, the hiring consequence is rarely more engineers; it is senior accountability, security, risk and data governance reporting high enough to change decisions. Across Americas, watch whether the response is a hire or a contractor; that distinction says how the board has read it.
Market context: MitchelLake's Talent Market Index sits at 122.7 (Hot), up 17.8 on the prior month; Americas hiring signal is running rising (+34.4pts).
Amgen: 3 signals in the last 90 days — above the Biotech & Pharma median of 1 across 32 tracked companies; 0.1% of MitchelLake's EMEA signal flow; 4 tracked across 79 days.
MitchelLake in this thematic
Also at Amgen →
More signals across Biotech & Pharma
Capital Raising · Americas
bioAffinity Technologies, Inc. →bioAffinity Technologies raised approximately $4 million through registered direct financing and concurrent private placement priced at-the-market under Nasdaq rules.
Partnership · Americas
Lotte Biologics →Lotte Biologics signed a manufacturing agreement with Alvotech to produce multiple antibody biosimilar drug substances at its Syracuse, New York facility, expanding its global manufacturing partnerships.
Geographic Expansion · Americas
BD (Becton Dickinson) →BD announces $19 billion U.S. investment partnership with government, including $3 billion for domestic medical manufacturing expansion
Leadership Change · Americas
Valion Bio Inc. →Valion Bio names Thomas H. Jensen, CEO of Allarity Therapeutics, as board chair to advance Entolimod program for acute radiation syndrome following company transformation
Product Launch · Americas
Thermo Fisher Scientific →Thermo Fisher Scientific launched Gibco CHO-K1 Catalog Panel, a cGMP-ready suite of chemically defined, animal origin-free basal and feed media in liquid and dry powder formats for CHO-K1 cell line support in biologics and biosimilars production.
Capital Raising · Americas
Click Therapeutics, Inc. →Click Therapeutics, Inc. filed SEC Form D for private placement, indicating capital raising activity in therapeutics/digital health space.
Where this lands in our work
- Executive Search: Americas →
Our Americas practice runs the searches behind signals like this one.
Intelligence powered by Autonodal ↗